This profile has not been claimed and data may not be accurate.
48th percentile
58th percentile
MIT scientist and co-founder of Ginkgo Bioworks turned angel investor
Credibility
GTM / Distribution · 62th percentile
- ginkgobioworks.com ranks #86,244 on the Majestic Million (global domain prominence).
Relationship Matrix
Most Complimentary
Founder score
- 95%Probability of being accurate (95%)ginkgobioworks.com ranks #86,244 on the Majestic Million (global domain prominence).
- 95%Probability of being accurate (95%)Past founder and co-founder of Ginkgo Bioworks.
- 95%Probability of being accurate (95%)Wikidata/Wikipedia entity exists for Tom Knight, confirming notable public profile.
- 90%Probability of being accurate (90%)Ginkgo Bioworks had co-founders alongside Tom Knight.
Investor score
- 80%Probability of being accurate (80%)Publicly identified as an angel investor with a portfolio of 2 companies in HealthTech and Life Sciences.
- 70%Probability of being accurate (70%)Has made 2 active angel investments per Tracxn portfolio data.
What you likely need
You're at a stage where your reputation in synthetic biology far exceeds your formal presence in the current funding ecosystem — the right rooms can convert your scientific authority into deal flow, advisory roles, and early-stage ownership. Festival events that put you in front of AI-bio founders seeking legitimacy, and institutional investors who backed Ginkgo and want your pattern-recognition, will create the most leverage. A few curated dinners and roundtables are all it takes to formalize what's already happening informally.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- positioningA dinner with founders of AI-driven biology startups (in the orbit of EvolutionaryScale, Latent Labs, and similar) actively seeking a 'godfather of synthetic biology' advisor whose name alone moves a fundraising round
- introsA roundtable connecting promising early-stage life-science founders with the institutional investors who backed Ginkgo Bioworks, facilitated by you as the warm-introduction bridge
- tacticalAn office-hours session with MIT Engine and Technology Licensing Office dealmakers to surface fundable spinout candidates from your current MIT research before they get scooped by competing labs
- introsA dinner with AngelList syndicate leads and life-science angel networks to help you formalize and publicize your investing activity so synthetic biology founders can find and pitch you directly
- fundraisingA curated dinner with top-tier biotech and deep-tech VCs actively deploying into the AI-biology wave, where you can expand your 2-company portfolio with high-conviction introductions on both sides
- positioningA roundtable with science communicators, MIT Technology Review editors, and Substack's top science writers to develop a publishing strategy that turns your synthetic biology expertise into regular inbound deal flow
- wellbeingAn intimate dinner with science historians, long-form science journalists, and fellow early synthetic biology pioneers (iGEM founders, early BioBricks contributors) to begin shaping the memoir or oral history your foundational work deserves